Table 2.
Classification of IBD mouse models evaluated within this study
Organ | “First hit” | Induction | Example | Sampling1 | Scheme |
---|---|---|---|---|---|
Colon | Outside | Induced by erosive chemicals | Oral DSS; single cycle | Distal colon, day 2-42 | 1 (Table 3, Figure 6) |
Oral DSS; repeated cycles | Distal colon, day 142 | ||||
Rectal TNBS; single dose | Distal colon, day 2-4 | ||||
Rectal oxazolone; single dose | Distal colon, day 2-4 | ||||
Mediated by luminal antigen | Rectal ovalbumin, transfer of OVA-specific CD8+ T cells | Colon3, week 6-8 | 2 (Table 4, Figure 7) | ||
Inside | Mediated by disturbed immune cell homeostasis | Transfer of naïve CD4+ T cells into syngeneic immunodeficient mice | Colon3, week 4-8 | 3 (Table 5, Figure 8) | |
Mediated by genetically altered cytokine balance | Homozygous IL-10ko | Ascending and transverse colon, week 34 | 4 (Table 6, Figure 9) | ||
Homozygous IL-2ko | Colon3, week 6-15 | ||||
Small intestine | Inside | Mediated by genetically altered cytokine balance | TNFΔARE/+ | Terminal ileum, week 4-8 | 5 (Table 7, Figure 10) |
Outside | Mediated by luminal antigen | Oral infection with H. polygyrus | Duodenum, day 6 | 6 (Table 8, Figure 11) | |
Oral infection with N. brasiliensis | Jejunum, day 7 | ||||
Oral infection with T. gondii | Ileum, day 7-8 | (Table 9, Figure 12) |
Most affected organ and time point of most severe inflammation; can vary according to the experimental setup;
After DSS removal;
Severity increases from proximal to distal colon;
Development of chronic colitis and adenocarcinoma ≥3 months of age.